Filter by
Filters
Filter results

Date

Primary topics

All topics

Types of content

All types

Products

All products

Diseases

All diseases

General Terms

All terms

Geography

All locations

Institutions & Events

All events and institutions
Apply
Clear all filters
24 results found
Report Cover Image
Letter |

Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis

The Public Health Center of the Ministry of Ukraine (PHC) sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve equitable access to the lifesaving TB drug bedaquiline in ...
Tags Intellectual property and trade tuberculosis bedaquiline Johnson & Johnson Ukraine
Report cover image
Letter |

Ukraine: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis

Civil society organisations, communities affected by tuberculosis (TB), and partner institutions in Ukraine sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve ...
Tags Tuberculosis tuberculosis bedaquiline Johnson & Johnson Ukraine
Patients and MSF staff perform a dance to welcome new members to the "six-months-meeting day" in Mbulumbuzi Health Centre for the Adolescent HIV project in Malawi, it also monitors all the girls and boy who have already joined the program.
Press release |

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

MSF calls out ViiV Healthcare—a division of US and UK pharmaceutical corporations Pfizer and GlaxoSmithKline plus Japan’s Shionogi—for preventing children with HIV from getting child-appropriate formulations of a critical HIV medicine ...
Tags HIV/AIDS HIV/AIDS dolutegravir Clinton FoundationUNITAIDWorld Health OrganizationInternational AIDS ConferenceGlaxoSmithKlinePfizerViiV KenyaMalawiNigeriaSouth Africa